Industry News | Latest News, Trends & Market Insights.
Stay Ahead with the Latest Industry Trends & Market Insights.
Overview On 28th January 2025, Zimmer Biomet Holdings, Inc., a leading global medical technology company, has announced a definitive agreement to acquire Paragon 28, Inc., a specialist in foot and ankle orthopedic devices, in a $1.2 billion transaction. The acquisition will be executed through an upfront cash payment of $13.00 per share, representing an equity…
On January 29, 2025, Huawei and Chinese automobile manufacturer JAC announced the development of two new models under their ultra-luxury brand, Maextro. This initiative follows the unveiling of their first model, the Maextro S800, which debuted at a Huawei press conference in November 2024. The S800, a full-sized luxury sedan, boasts a starting pre-sale price…
Inogen, Inc. announced a strategic collaboration with Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. (Yuwell), enhancing Inogen’s product offerings, expanding its global presence, and bolstering its innovation pipeline. As part of this agreement, Yuwell will distribute specific respiratory products through Inogen in the United States and other territories, while Inogen will capitalize on the…
Researchers at the Experimental and Clinical Research Center (ECRC) in Berlin have made a significant breakthrough in the development of a gene-editing therapy for muscular dystrophy, specifically targeting limb-girdle muscular dystrophy (LGMD). Led by Professor Simone Spuler and Dr. Helena Escobar, this promising approach utilizes CRISPR-Cas9 technology to correct genetic mutations responsible for muscle degeneration…
Preclinical research from the University of North Carolina Lineberger Comprehensive Cancer Center has revealed a promising cocktail of three different drugs that could potentially enhance CAR-T (chimeric antigen receptor-T) cell therapy for cancer treatment. This discovery has the potential to significantly improve the production of CAR-T cells for clinical use by boosting the immune system’s…
Takeda, a leading Japanese pharmaceutical company, has announced the launch of its new Innovation Centre, with a strong focus on leveraging artificial intelligence (AI) and digital technologies to drive the next phase of pharmaceutical innovation. The company aims to harness AI to improve drug discovery, optimize clinical trials, and accelerate the development of new therapies,…
Biocon, a leading biopharmaceutical company, has urged the Indian government to exempt cancer and rare-disease drugs from taxes in the upcoming Union Budget. This plea is a part of the company’s broader efforts to ensure that life-saving medicines remain affordable for patients battling critical conditions. The company believes that tax exemptions on these specialized drugs…
“Prevention is better than care” as they say, this age-old phrase has never been more relevant. With the aging population, rising incidence of chronic diseases, and skyrocketing healthcare costs, the public health focus is shifting toward preventive medicine. Several governments across the world are prioritizing public health and investing in preventive healthcare practices. Before a…
On January 15, 2025, BD (Becton, Dickinson and Company) Announced additional investments to expand its U.S. manufacturing network, thereby improving the production of critical medical devices such as IV catheters, needles, and syringes. The objective of these endeavors is to fortify the resilience of the supply chain and address the persistent requirements of the U.S….
The cost of prescription drugs in the U.S. is projected to continue rising in 2025 and beyond, driven by a steady stream of high-cost treatments. A recent survey by TD Cowen, based on feedback from 27 health organizations, pharmacies, and hospitals representing about one-fourth of total U.S. drug spending in 2024 ($179 billion) shows that…
On January 14, 2025, Argon Medical Devices announced the acquisition of the SeQure® and DraKon™ microcatheters from Accurate Medical Therapeutics, Ltd., previously distributed by Guerbet SA. This acquisition bolsters Argon’s offerings for interventional oncology by adding therapeutic devices to its established diagnostic oncology product line, which includes biopsy devices. Microcatheters, including SeQure and DraKon, are…
As the Alzheimer’s drug market intensifies, Biogen is preparing for a fierce competition against Eli Lilly’s newly approved Alzheimer’s treatment, Kisunla. Biogen’s CEO Chris Viehbacher expressed confidence at the J.P. Morgan Healthcare Conference, stating that his company is ready to “stand our ground” in the Alzheimer’s treatment race, despite the challenge posed by Eli Lilly’s…
Avel eCare has acquired Amwell Psychiatric Care, a division of Amwell, to expand its behavioral health services across the United States. This acquisition will allow Avel to extend its reach into 46 states, helping to meet the growing demand for mental health care. By integrating Amwell’s expertise, Avel aims to streamline the process for patients…
As we look ahead to 2025, the pharmaceutical industry is set for some major shifts, with several top-selling drugs dominating the market. While AbbVie’s Humira continues to be a major player, it is expected to be overtaken by newer drugs with promising market potentials. Here are the Top 10 Pharmaceutical Breakthroughs poised to lead the…
Introduction Global Food Grade Lecithin Market reached US$ 21.32 billion in 2024 and is expected to reach US$ 30.60 billion by 2032, growing with a CAGR of 4.62% during the forecast period 2025-2032. Food-grade lecithin is a natural emulsifier and stabilizer derived from sources like soybeans, sunflower seeds, eggs or rapeseed, specifically processed for use…
Global Clean Label Emulsifiers Market reached US$ 813.47 million in 2022 and is expected to reach US$ 1526.63 million by 2031, growing with a CAGR of 7.24% during the forecast period 2024-2031 What are Clean Label Emulsifiers? Clean-label emulsifiers are food additives and ingredients derived from plants or animals, such as starch, flavourings, malt, wheat,…
Global Blue Ammonia Market reached US$ 2.3 billion in 2022 and is expected to reach US$ 76.7 billion by 2031, growing at CAGR of 55.2% during the forecast period 2024-2031 What is Blue Ammonia? Blue ammonia is a low-carbon form of ammonia produced by combining nitrogen with “blue” hydrogen derived from natural gas, where carbon…
What is oropouche fever? Oropouche fever caused by the Oropouche virus (OROV) is predominant in Central America, South America, and the Caribbean region. The virus spreads to humans through biting midges and mosquitoes. The common symptoms of oropouche fever are similar to dengue and include: In some patients, Oropouche fever case cause Why the sudden…